2ccPA

DRUG2 trials

Sponsors

Orient Europharma Co., Ltd.

Conditions

Osteoarthritis (OA) of the KneeOsteoarthritis, Knee

Phase 1

2ccPA Study in Patients With Symptomatic Knee Osteoarthritis

CompletedNCT04229394

Orient Europharma Co., Ltd.Osteoarthritis (OA) of the Knee

Start: 2018-02-13End: 2021-03-22Updated: 2021-04-30

A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis

Active, not recruitingNCT05807529

Orient Europharma Co., Ltd.Osteoarthritis, Knee

Start: 2022-11-03End: 2024-12-31Target: 136Updated: 2024-03-21